Key findings: 10% reduction in LDL cholesterol Average 2kg weight loss Improved blood pressure Benefits sustained 6 weeks post-intervention This research opens new possibilities for preventative health strategies in metabolic syndrome management
Key takeaways Ozempic and compounded semaglutide contain the same active ingredient used to treat Type 2 diabetes and obesity
Traditional GLP-1 weight-loss treatments (such as Saxenda , Ozempic , or Mounjaro ) are typically approved for people with a BMI over 30, or over 27 with medical conditions such as diabetes or high blood pressure
This study evaluated the comparative cardioprotective effects of GLP-1 RAs versus SGLT2-i in adults with PAH using large-scale real-world data
Explicit-pH coarse-grained molecular dynamics simulations enable insights into restructuring of intestinal colloidal aggregates with permeation enhancers
White House spokesman Kush Desai said in an email Thursday that TrumpRx is offering consumers weight loss drugs at deeply discounted prices compared to what they previously had access to. The other disruptive factor has been a proliferation of compounding pharmacies selling weight-loss drugs at lower prices than the brand companies